DQ 6.2: What other issues (aside from regulatory compliance) do you foresee arising if drug and device companies start engaging in more social media activity, such as recruitment for clinical trial participants, study design, and creating brand awareness? How might the use of social media help companies overcome barriers to clinical trial participation by racial minorities and other marginalized populations